Earnings Feed
Start Free
AEOLUS PHARMACEUTICALS, INC.·4

Mar 6, 2:52 PM ET

Suzdak Peter David 4

4 · AEOLUS PHARMACEUTICALS, INC. · Filed Mar 6, 2013

Insider Transaction Report

Form 4
Period: 2011-04-13
AEOLUS PHARMACEUTICALS, INC.AOLS
Suzdak Peter David
Director
Transactions
  • Award

    Non-qualified Stock Option (right to buy)

    2012-03-20+11,250→ 11,250 total
    Exercise: $0.31Exp: 2022-03-20→ Common Stock (11,250 underlying)
  • Award

    Non-qualified Stock Option (right to buy)

    2012-07-11+11,250→ 11,250 total
    Exercise: $0.23Exp: 2022-07-11→ Common Stock (11,250 underlying)
  • Award

    Non-qualified Stock Option (right to buy)

    2011-04-13+11,250→ 11,250 total
    Exercise: $0.50Exp: 2021-04-13→ Common Stock (11,250 underlying)
  • Award

    Non-qualified Stock Option (right to buy)

    2011-11-07+11,250→ 11,250 total
    Exercise: $0.40Exp: 2021-11-07→ Common Stock (11,250 underlying)
  • Award

    Non-qualified Stock Option (right to buy)

    2012-10-09+11,250→ 11,250 total
    Exercise: $0.35Exp: 2022-10-09→ Common Stock (11,250 underlying)
Footnotes (1)
  • [F1]Option will vest in equal monthly installments over a period of twelve months from the date of grant, provided that the Director remains on the Board of Directors of the Company.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT